User profiles for Hussain A. Al-Omar

Hussain A Al-Omar

Associate Professor of Pharmacoeconomics, College of Pharmacy, Department of
Verified email at ksu.edu.sa
Cited by 441

The ticking time bomb in lifestyle-related diseases among women in the Gulf Cooperation Council countries; review of systematic reviews

MK Alshaikh, FT Filippidis, HA Al-Omar, S Rawaf… - BMC public health, 2017 - Springer
Background This study aims to review all published systematic reviews on the prevalence of
modifiable cardiovascular disease risk factors among women from the Gulf Cooperation …

Criteria to define rare diseases and orphan drugs: a systematic review protocol

GM Abozaid, K Kerr, A McKnight, HA Al-Omar - BMJ open, 2022 - bmjopen.bmj.com
Introduction Rare diseases (RDs) are often chronic and progressive life-threatening medical
conditions that affect a low percentage of the population compared with other diseases. …

[HTML][HTML] The impact of perceived organizational support and resilience on pharmacists' engagement in their stressful and competitive workplaces in Saudi Arabia

HA Al-Omar, AM Arafah, JM Barakat… - Saudi Pharmaceutical …, 2019 - Elsevier
Background In recent years, organizations around the globe have begun measuring the
engagement level of employees in order to improve productivity and profitability. Employee …

Prescribing of potentially inappropriate medications among the elderly population in an ambulatory care setting in a Saudi military hospital: trend and cost

HA AlOmar, MS Al‐Sultan… - Geriatrics & gerontology …, 2013 - Wiley Online Library
Aim: To explore the prevalence of potentially inappropriate medication (PIM) use in the elderly,
to identify the trends and the patterns of prescribing such medication, and to calculate the …

Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians

NY Sultan, A YacoobMayet, SA Alaqeel, HA Al-Omar - BMC Public Health, 2018 - Springer
Background Egypt has the largest proportion of hepatitis C virus (HCV) infection worldwide
and there is an urgent need to increase community awareness and knowledge about the …

What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions

HA Al-Omar, AA Attuwaijri, IA Aljuffali - Expert review of …, 2020 - Taylor & Francis
Objectives Saudi Arabia is undergoing a massive health-care transformation to fulfill its new,
national ‘Vision 2030.’ To align with this objective, Saudi Arabia is establishing a new, …

Obesity burden and impact of weight loss in Saudi Arabia: A modelling study

SA Alqahtani, HA Al-Omar, A Alshehri, A Abanumay… - Advances in …, 2023 - Springer
Background Obesity and its complications are associated with morbidity, mortality and high
economic cost in Saudi Arabia. Estimating this impact at the population level and potential …

The impact of obesity in Saudi Arabia: healthcare resource use and costs associated with obesity-related complications

HA Al-Omar, A Alshehri, A Abanumay… - Advances in …, 2023 - Springer
Introduction Saudi Arabia has a high prevalence of obesity, which increases the risk of
individuals experiencing multiple chronic complications. Only a few publications highlight the …

Budget impact analysis of transcatheter aortic valve replacement in low, intermediate, and high-risk patients with severe aortic stenosis in Saudi Arabia

JL Carapinha, HA Al-Omar, F Alqoofi… - Journal of Medical …, 2022 - Taylor & Francis
Aims A budget impact analysis (BIA) comparing transcatheter aortic valve replacement (TAVR)
with SAPIEN 3 and surgical aortic valve replacement (SAVR) for severe, symptomatic …

[HTML][HTML] Pharmaceutical companies' views on a health technology assessment (HTA) entity in Saudi Arabia

HA Al-Omar, AA Attuwaijri, IA Aljuffali - Saudi Pharmaceutical Journal, 2020 - Elsevier
Saudi Arabia is undergoing a massive healthcare transformation to fulfill its new, national “Vision
2030.” To align with this objective, Saudi Arabia is establishing a new, independent …